LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL

LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL was reported 270 times

LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 UTERINE FISTULA 1 0.0303
1 PRODUCT DIFFICULT TO REMOVE 1 0.0167
2 NASAL SEPTUM ULCERATION 1 0.0161
3 MALIGNANT MESENTERIC NEOPLASM 1 0.0132
4 RETINOSCHISIS 1 0.0072
5 PINEAL GLAND CYST 1 0.0071
6 NEUROSYPHILIS 1 0.0066
7 CAROTID ARTERY DISSECTION 2 0.0047
8 KLEBSIELLA URINARY TRACT INFECTION 1 0.0038
9 ARTERIOVENOUS FISTULA OPERATION 1 0.0037
10 BACTERIAL TEST 1 0.0034
11 VAGINAL LESION 1 0.0033
12 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
13 TUMOUR RUPTURE 1 0.0018
14 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
15 NASAL SEPTUM PERFORATION 1 0.0015
16 PRODUCT PACKAGE ASSOCIATED INJURY 3 0.0013
17 SEIZURE CLUSTER 1 0.0012
18 STARVATION 1 0.0012
19 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
20 BLADDER CATHETERISATION 1 0.0010
21 PRODUCT BLISTER PACKAGING ISSUE 1 0.0010
22 CHRONIC SPONTANEOUS URTICARIA 1 0.0009
23 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
24 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
25 PREGNANCY ON ORAL CONTRACEPTIVE 2 0.0008
26 MAST CELL ACTIVATION SYNDROME 1 0.0007
27 METRORRHAGIA 12 0.0007
28 HAEMORRHAGE IN PREGNANCY 1 0.0007
29 PREGNANCY ON CONTRACEPTIVE 1 0.0007
30 PULMONARY VALVE INCOMPETENCE 1 0.0007
31 GASTROSTOMY 1 0.0006
32 URINE KETONE BODY PRESENT 1 0.0006
33 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
34 MITRAL VALVE PROLAPSE 1 0.0006
35 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
36 EXPOSURE TO SARS-COV-2 1 0.0006
37 INFUSION SITE DISCHARGE 1 0.0006
38 UTERINE SPASM 1 0.0005
39 CYSTIC FIBROSIS 3 0.0005
40 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
41 MYELOPATHY 1 0.0005
42 VASCULAR STENT THROMBOSIS 1 0.0005
43 NEUROGENIC BLADDER 1 0.0005
44 DEREALISATION 1 0.0005
45 OLIGOMENORRHOEA 1 0.0005
46 MENORRHAGIA 9 0.0005
47 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
48 UTERINE LEIOMYOMA 3 0.0004
49 VASODILATATION 1 0.0004
50 AMMONIA INCREASED 2 0.0004
51 ABNORMAL UTERINE BLEEDING 1 0.0004
52 ANAL FISTULA 2 0.0004
53 ANAL ABSCESS 2 0.0004
54 HYPOMENORRHOEA 1 0.0004
55 RHINALGIA 1 0.0004
56 LUNG CONSOLIDATION 1 0.0004
57 SKIN SWELLING 3 0.0003
58 URINE ANALYSIS ABNORMAL 1 0.0003
59 ACNE CYSTIC 1 0.0003
60 INFUSION SITE PRURITUS 1 0.0003
61 HEPATIC NEOPLASM 1 0.0003
62 BREAST ENLARGEMENT 1 0.0003
63 THROMBOSIS IN DEVICE 1 0.0003
64 SUSPECTED COVID-19 1 0.0003
65 PEPTIC ULCER 1 0.0003
66 TONGUE ULCERATION 1 0.0003
67 POLYMENORRHOEA 1 0.0003
68 HANGOVER 1 0.0003
69 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
70 ASTHMATIC CRISIS 1 0.0003
71 HEPATOCELLULAR CARCINOMA 2 0.0003
72 WOUND SECRETION 1 0.0003
73 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
74 SKIN ODOUR ABNORMAL 1 0.0003
75 RECURRENT CANCER 1 0.0002
76 HYPERURICAEMIA 1 0.0002
77 HORDEOLUM 1 0.0002
78 HEAVY MENSTRUAL BLEEDING 2 0.0002
79 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
80 YELLOW SKIN 1 0.0002
81 VAGINAL INFECTION 1 0.0002
82 PRODUCT PACKAGING ISSUE 2 0.0002
83 ENDOMETRIOSIS 1 0.0002
84 RASH VESICULAR 1 0.0002
85 HORMONE LEVEL ABNORMAL 1 0.0002
86 PROTEIN URINE PRESENT 1 0.0002
87 DYSLIPIDAEMIA 1 0.0002
88 PETIT MAL EPILEPSY 1 0.0002
89 PARTIAL SEIZURES 1 0.0002
90 INTESTINAL RESECTION 1 0.0002
91 ERYTHEMA OF EYELID 1 0.0002
92 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
93 DERMATITIS CONTACT 2 0.0002
94 VENTRICULAR SEPTAL DEFECT 1 0.0002
95 METABOLIC DISORDER 1 0.0002
96 COVID-19 PNEUMONIA 2 0.0002
97 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
98 PRODUCT DOSE OMISSION 11 0.0002
99 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
100 DRUG DIVERSION 1 0.0002
101 VAGINAL HAEMORRHAGE 7 0.0002
102 PRE-EXISTING CONDITION IMPROVED 1 0.0002
103 INFUSION SITE SWELLING 1 0.0002
104 SLEEP APNOEA SYNDROME 3 0.0002
105 CARDIAC FLUTTER 1 0.0002
106 DERMATITIS ATOPIC 8 0.0002
107 DYSMENORRHOEA 2 0.0002
108 BRONCHIECTASIS 1 0.0001
109 METASTASES TO LYMPH NODES 1 0.0001
110 SINUS CONGESTION 2 0.0001
111 EYE MOVEMENT DISORDER 1 0.0001
112 ONYCHOCLASIS 1 0.0001
113 DIVERTICULUM 1 0.0001
114 METASTASIS 1 0.0001
115 IMPAIRED QUALITY OF LIFE 2 0.0001
116 PANIC REACTION 1 0.0001
117 INTENTIONAL UNDERDOSE 1 0.0001
118 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
119 ARTHROPOD BITE 1 0.0001
120 BREAST TENDERNESS 1 0.0001
121 DISSOCIATION 1 0.0001
122 APNOEA 1 0.0001
123 MULTIPLE ALLERGIES 1 0.0001
124 NASAL DISCOMFORT 1 0.0001
125 TRICUSPID VALVE INCOMPETENCE 1 0.0001
126 MYASTHENIA GRAVIS 1 0.0001
127 PRODUCT SUBSTITUTION ISSUE 7 0.0001
128 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
129 VITAMIN D DECREASED 1 0.0001
130 THERAPY CESSATION 6 0.0001
131 CARDIAC OPERATION 1 0.0001
132 AMENORRHOEA 2 0.0001
133 THIRST 2 0.0001
134 LEUKOCYTOSIS 2 0.0001
135 HIDRADENITIS 1 0.0001
136 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
137 BLOOD URINE PRESENT 2 0.0001
138 DIZZINESS POSTURAL 1 0.0001
139 EMBEDDED DEVICE 1 0.0001
140 HYPOTONIA 1 0.0001
141 OVARIAN CYST 1 0.0001
142 BRAIN INJURY 1 0.0001
143 POOR QUALITY DEVICE USED 1 0.0001
144 NEUTROPHIL COUNT INCREASED 1 0.0001
145 INITIAL INSOMNIA 1 0.0001
146 ECZEMA 5 0.0001
147 MOOD SWINGS 3 0.0001
148 BREAST PAIN 1 0.0001
149 MENSTRUATION DELAYED 1 0.0001
150 SKIN LACERATION 1 0.0001
151 PULMONARY THROMBOSIS 1 0.0001
152 TOOTH FRACTURE 1 0.0001
153 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
154 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
155 STATUS EPILEPTICUS 1 0.0001
156 MITRAL VALVE INCOMPETENCE 1 0.0001
157 MICTURITION URGENCY 1 0.0001
158 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
159 CHOLECYSTECTOMY 1 0.0001
160 METASTASES TO LUNG 1 0.0001
161 EYELID OEDEMA 1 0.0001
162 NOCTURIA 1 0.0001
163 DISCOMFORT 5 0.0001
164 SPINAL OPERATION 1 0.0001
165 CYST 1 0.0001
166 DERMATITIS ALLERGIC 1 0.0001
167 EXPOSURE VIA SKIN CONTACT 2 0.0001
168 SPEECH DISORDER 4 0.0001
169 IMMUNE SYSTEM DISORDER 1 0.0001
170 SARS-COV-2 TEST POSITIVE 1 0.0001
171 HAIR TEXTURE ABNORMAL 1 0.0001
172 QUALITY OF LIFE DECREASED 1 0.0001
173 PRODUCT TASTE ABNORMAL 1 0.0001
174 DEVICE MECHANICAL ISSUE 1 0.0001
175 DIVERTICULITIS 2 0.0001
176 POLLAKIURIA 3 0.0001
177 COORDINATION ABNORMAL 1 0.0001
178 DEVICE OCCLUSION 1 0.0001
179 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
180 INTENTIONAL DOSE OMISSION 2 0.0001
181 APATHY 1 0.0001
182 DYSSTASIA 2 0.0001
183 DEVICE RELATED INFECTION 1 0.0001
184 THYROID DISORDER 1 0.0001
185 LIMB DISCOMFORT 2 0.0001
186 MUSCULOSKELETAL CHEST PAIN 1 0.0001
187 OBESITY 1 0.0001
188 ABSCESS 1 0.0001
189 NIGHT SWEATS 2 0.0001
190 PERICARDITIS 1 0.0001
191 SLEEP DISORDER 4 0.0001
192 LYMPHADENOPATHY 2 0.0001
193 GASTROENTERITIS VIRAL 1 0.0001
194 PELVIC PAIN 1 0.0001
195 CONJUNCTIVITIS 1 0.0001
196 PRODUCT USE ISSUE 10 0.0001
197 ACNE 4 0.0001
198 INCREASED APPETITE 1 0.0001
199 POST PROCEDURAL COMPLICATION 1 0.0001
200 SURGERY 3 0.0001
201 PRODUCT DOSE OMISSION ISSUE 15 0.0001
202 SINUS DISORDER 1 0.0001
203 HAEMATOCRIT DECREASED 1 0.0001
204 THROMBOSIS 4 0.0000
205 PRODUCT ADMINISTRATION ERROR 1 0.0000
206 FEEDING DISORDER 1 0.0000
207 INJURY ASSOCIATED WITH DEVICE 1 0.0000
208 DERMATITIS 1 0.0000
209 EATING DISORDER 1 0.0000
210 IMPAIRED WORK ABILITY 1 0.0000
211 POOR QUALITY SLEEP 1 0.0000
212 RHINORRHOEA 3 0.0000
213 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
214 PSORIASIS 6 0.0000
215 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
216 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
217 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
218 ADVERSE DRUG REACTION 4 0.0000
219 PRODUCT AVAILABILITY ISSUE 1 0.0000
220 MEMORY IMPAIRMENT 6 0.0000
221 MUSCLE SPASMS 8 0.0000
222 DISEASE RECURRENCE 2 0.0000
223 PRODUCT PRESCRIBING ERROR 1 0.0000
224 MIGRAINE 4 0.0000
225 MENTAL IMPAIRMENT 1 0.0000
226 INJECTION SITE URTICARIA 1 0.0000
227 LIVER INJURY 1 0.0000
228 WEIGHT INCREASED 9 0.0000
229 DRY EYE 2 0.0000
230 HOT FLUSH 3 0.0000
231 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
232 FLUSHING 4 0.0000
233 PRURITUS 15 0.0000
234 UNRESPONSIVE TO STIMULI 1 0.0000
235 NO ADVERSE EVENT 7 0.0000
236 RESPIRATORY TRACT INFECTION 1 0.0000
237 HAEMORRHAGE 4 0.0000
238 SEDATION 1 0.0000
239 JOINT STIFFNESS 1 0.0000
240 EAR INFECTION 1 0.0000
241 MENSTRUATION IRREGULAR 1 0.0000
242 FREQUENT BOWEL MOVEMENTS 1 0.0000
243 RASH PRURITIC 2 0.0000
244 PNEUMONITIS 1 0.0000
245 MOOD ALTERED 1 0.0000
246 TREATMENT NONCOMPLIANCE 2 0.0000
247 ASTHMA 4 0.0000
248 HYPERSOMNIA 1 0.0000
249 SEIZURE 4 0.0000
250 NEEDLE ISSUE 1 0.0000
251 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
252 NASAL CONGESTION 2 0.0000
253 TACHYCARDIA 3 0.0000
254 WHEEZING 2 0.0000
255 RESPIRATORY DISORDER 1 0.0000
256 IRRITABILITY 2 0.0000
257 ILL-DEFINED DISORDER 2 0.0000
258 PLEURAL EFFUSION 2 0.0000
259 EPILEPSY 1 0.0000
260 BLOOD PRESSURE INCREASED 5 0.0000
261 INJECTION SITE RASH 1 0.0000
262 EMOTIONAL DISORDER 1 0.0000
263 HEAD INJURY 1 0.0000
264 HYPOTHYROIDISM 1 0.0000
265 ALOPECIA 6 0.0000
266 URINARY RETENTION 1 0.0000
267 DRY SKIN 4 0.0000
268 URTICARIA 5 0.0000
269 EYE PRURITUS 1 0.0000
270 SINUSITIS 3 0.0000
271 RASH MACULAR 1 0.0000
272 BURNING SENSATION 2 0.0000
273 COVID-19 5 0.0000
274 HYPOXIA 1 0.0000
275 THERAPY INTERRUPTED 2 0.0000
276 CRYING 1 0.0000
277 PANIC ATTACK 1 0.0000
278 ACCIDENTAL OVERDOSE 1 0.0000
279 RESTLESSNESS 1 0.0000
280 INJECTION SITE MASS 1 0.0000
281 INFLUENZA 3 0.0000
282 DYSARTHRIA 1 0.0000
283 UNEVALUABLE EVENT 2 0.0000
284 COLITIS 1 0.0000
285 DEPRESSION 6 0.0000
286 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
287 PARAESTHESIA 4 0.0000
288 ABNORMAL BEHAVIOUR 1 0.0000
289 RASH 11 0.0000
290 DEVICE BREAKAGE 1 0.0000
291 DYSKINESIA 1 0.0000
292 DRUG DOSE OMISSION 4 0.0000
293 ABDOMINAL DISCOMFORT 4 0.0000
294 URINARY TRACT INFECTION 4 0.0000
295 RECTAL HAEMORRHAGE 1 0.0000
296 BALANCE DISORDER 2 0.0000
297 DEVICE DISLOCATION 1 0.0000
298 MENTAL DISORDER 1 0.0000
299 CONSTIPATION 5 0.0000
300 PRODUCT STORAGE ERROR 2 0.0000
301 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
302 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
303 PRODUCT QUALITY ISSUE 3 0.0000
304 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
305 PNEUMONIA 7 0.0000
306 NAUSEA 17 0.0000
307 COGNITIVE DISORDER 1 0.0000
308 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
309 PULMONARY EMBOLISM 2 0.0000
310 RASH ERYTHEMATOUS 1 0.0000
311 MULTIPLE SCLEROSIS 1 0.0000
312 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
313 HEADACHE 13 0.0000
314 HEART RATE INCREASED 2 0.0000
315 HOSPITALISATION 3 0.0000
316 ABDOMINAL PAIN UPPER 4 0.0000
317 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
318 INFLAMMATION 1 0.0000
319 NERVOUSNESS 1 0.0000
320 DIARRHOEA 12 0.0000
321 DISTURBANCE IN ATTENTION 1 0.0000
322 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
323 HAEMATOCHEZIA 1 0.0000
324 TREMOR 3 0.0000
325 ARTHROPATHY 1 0.0000
326 BLISTER 1 0.0000
327 HERPES ZOSTER 1 0.0000
328 LETHARGY 1 0.0000
329 EYE IRRITATION 1 0.0000
330 ABDOMINAL PAIN 4 0.0000
331 EMOTIONAL DISTRESS 2 0.0000
332 STOMATITIS 1 0.0000
333 CONDITION AGGRAVATED 5 0.0000
334 FEELING HOT 1 0.0000
335 CHEST PAIN 3 0.0000
336 INJECTION SITE ERYTHEMA 2 0.0000
337 DYSPNOEA 9 0.0000
338 DEEP VEIN THROMBOSIS 1 0.0000
339 AMNESIA 1 0.0000
340 DEHYDRATION 2 0.0000
341 NEOPLASM MALIGNANT 1 0.0000
342 INJECTION SITE PRURITUS 1 0.0000
343 SOMNOLENCE 3 0.0000
344 VOMITING 7 0.0000
345 ERYTHEMA 3 0.0000
346 PYREXIA 5 0.0000
347 COUGH 4 0.0000
348 DEVICE MALFUNCTION 1 0.0000
349 INJURY 1 0.0000
350 HYPERTENSION 3 0.0000
351 FATIGUE 11 0.0000
352 SKIN BURNING SENSATION 1 0.0000
353 INFECTION 2 0.0000
354 BRONCHITIS 1 0.0000
355 DYSGEUSIA 1 0.0000
356 INJECTION SITE SWELLING 1 0.0000
357 INJECTION SITE PAIN 4 0.0000
358 BACK PAIN 3 0.0000
359 DRUG DOSE OMISSION BY DEVICE 1 0.0000
360 ARTHRITIS 1 0.0000
361 FEELING ABNORMAL 3 0.0000
362 CONFUSIONAL STATE 2 0.0000
363 CARDIAC ARREST 1 0.0000
364 FALL 4 0.0000
365 SKIN EXFOLIATION 1 0.0000
366 INTENTIONAL PRODUCT MISUSE 1 0.0000
367 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
368 MUSCULOSKELETAL STIFFNESS 1 0.0000
369 DRUG WITHDRAWAL SYNDROME 1 0.0000
370 INSOMNIA 3 0.0000
371 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
372 SUICIDAL IDEATION 1 0.0000
373 NASOPHARYNGITIS 2 0.0000
374 OROPHARYNGEAL PAIN 1 0.0000
375 HYPERSENSITIVITY 2 0.0000
376 WEIGHT DECREASED 3 0.0000
377 CARDIAC DISORDER 1 0.0000
378 DYSPHAGIA 1 0.0000
379 DYSPEPSIA 1 0.0000
380 DRUG INEFFECTIVE 13 0.0000
381 CHEST DISCOMFORT 1 0.0000
382 ILLNESS 1 0.0000
383 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
384 OFF LABEL USE 8 0.0000
385 SEPSIS 1 0.0000
386 RHEUMATOID ARTHRITIS 1 0.0000
387 MUSCULAR WEAKNESS 1 0.0000
388 PAIN 5 0.0000
389 VISUAL IMPAIRMENT 1 0.0000
390 LOSS OF CONSCIOUSNESS 1 0.0000
391 ANXIETY 2 0.0000
392 MALAISE 3 0.0000
393 HYPOAESTHESIA 1 0.0000
394 DIZZINESS 3 0.0000
395 BLOOD GLUCOSE INCREASED 1 0.0000
396 GAIT DISTURBANCE 1 0.0000
397 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
398 ARTHRALGIA 2 0.0000
399 OVERDOSE 1 0.0000
400 DECREASED APPETITE 1 0.0000
401 PAIN IN EXTREMITY 1 0.0000
402 DEATH 1 0.0000